Acute HIV-1 infection presenting with fulminant encephalopathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun J. | - |
dc.contributor.author | Kim, Young H. | - |
dc.contributor.author | Lee, Jeong Y. | - |
dc.contributor.author | Sunwoo, Jun-Sang | - |
dc.contributor.author | Park, Se Y. | - |
dc.contributor.author | Kim, Tae H. | - |
dc.date.accessioned | 2021-08-11T14:24:37Z | - |
dc.date.available | 2021-08-11T14:24:37Z | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 0956-4624 | - |
dc.identifier.issn | 1758-1052 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7279 | - |
dc.description.abstract | Human immunodeficiency virus ( HIV)-1 directly affects the nervous system, causes distinct neurological symptoms, and indirectly results in opportunistic infections, which include herpes virus simplex ( HSV)-1, HSV-2, varicella zoster virus, and cytomegalovirus encephalitis caused by immunodeficiency. Early HIV-1 invasion of the central nervous system is also possible, and acute encephalopathy is a potentially lethal complication. We encountered a case of fulminant encephalopathy as a primary presentation of acute HIV-1 infection, in which highly active antiretroviral treatment resulted in a full clinical recovery. This case highlights the importance of considering acute HIV-1 infection in the differential diagnosis of reversible encephalopathy. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Royal Society of Medicine | - |
dc.title | Acute HIV-1 infection presenting with fulminant encephalopathy | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1177/0956462417693734 | - |
dc.identifier.scopusid | 2-s2.0-85026754858 | - |
dc.identifier.wosid | 000406702300013 | - |
dc.identifier.bibliographicCitation | International Journal of STD and AIDS, v.28, no.10, pp 1041 - 1044 | - |
dc.citation.title | International Journal of STD and AIDS | - |
dc.citation.volume | 28 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1041 | - |
dc.citation.endPage | 1044 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | ANTIRETROVIRAL THERAPY | - |
dc.subject.keywordAuthor | Human immunodeficiency virus | - |
dc.subject.keywordAuthor | highly active antiretroviral treatment | - |
dc.subject.keywordAuthor | infection | - |
dc.subject.keywordAuthor | encephalopathy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.